Oncoinvent Receives FDA Fast Track Designation for Radspherin® as Treatment for Peritoneal Carcinomatosis from Ovarian…
Continue Reading-
Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease
Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease Bagsværd, Denmark, and…
Continue Reading -
ARTHEx Biotech Receives IND Clearance from FDA to Initiate the Phase I-IIa
ARTHEx Biotech Receives IND Clearance from FDA to Initiate the Phase I-IIa...
Continue Reading -
Hadean Ventures announces oversubscribed final close of Hadean Capital II
Hadean Ventures announces oversubscribed final close of Hadean Capital II
Continue Reading -
Ribbon Biolabs appoints Jodi Barrientos Chief Executive Officer
Ribbon Biolabs appoints Jodi Barrientos Chief Executive Officer; Founder Harold De Vladar named an advisor…
Continue Reading -
Complement Therapeutics Enrols First US Participant
Complement Therapeutics Enrols First US Participant in the Non-interventional i-GAIN Study of People Diagnosed with…
Continue Reading -
Abliva Achieves Important Milestone in the Ongoing FALCON Study
Abliva AB (Nasdaq Stockholm: ABLI) a clinical-stage company developing drugs for the treatment of rare…
Continue Reading -
Abliva’s Lead Candidate KL1333 Receives FDA Fast Track Designation
Abliva’s Lead Candidate KL1333 Receives FDA Fast Track Designation Abliva AB (Nasdaq Stockholm: ABLI) a…
Continue Reading -
ARTHEx Biotech Announces Closing of €42 M Series B Financing
ARTHEx Biotech Announces Closing of €42 M Series B Financing to Advance ATX-01, its Novel…
Continue Reading -
Complement Therapeutics Secures €72 Million in Series A Financing
Complement Therapeutics Secures €72 Million in Series A Financing...
Continue Reading